School of Medicine, Jiangsu University, Zhenjiang, P. R. China.
School of Public Health, China Medical University, Shenyang, P. R. China.
Hum Vaccin Immunother. 2021 Nov 2;17(11):3963-3968. doi: 10.1080/21645515.2021.1954441. Epub 2021 Aug 4.
COVID-19 vaccination has been accepted widely. However, there are only a few reports on patients' willingness to be vaccinated. This study investigated the willingness of Chinese outpatients to accept COVID-19 vaccination as well as influencing factors.
A cross-sectional survey was conducted in Jiangsu province, China in December 2020. Self-administered questionnaires, which were distributed to 625 outpatients among secondary hospitals, addressed demographic characteristics, sociological characteristics, and subjective reasons. There were 522 (83.5%) participants who gave completely valid responses. Logistic regression analysis was performed to explore the risk factors for willingness of COVID-19 vaccination.
71.5% of participants were willing to receive the COVID-19 vaccine. "worried about contracting COVID-19" (49.6%) and "vaccines have just been introduced and need time to consider" (38.9%) were the main reasons for being willing and unwilling to receive COVID-19 vaccine, respectively. The logistic regression analysis showed that "vaccines are an effective way to prevent diseases" (OR = 5.07, 95%CI: 3.32-7.75), "the price you are willing to pay for non-free vaccines (yuan) (101-500 vs ≤100)″ (OR = 1.87, 95%CI: 1.16-3.02), "per capital monthly income(yuan) (>6000 vs ≤3000)"(OR = 2.13, 95%CI: 1.03-4.41), and "self- assessed health status (Good vs Bad)″ (OR = 1.71, 95%CI: 1.01-2.90) were the main risk factors for outpatients to be willing to receive the COVID-19 vaccine.
The willingness of Chinese outpatients to receive COVID-19 vaccine was not high. The government should do more to increase publicity of knowledge about COVID-19 vaccine thus increasing willingness to vaccinate, and provide free vaccine to eliminate the cost impact.
COVID-19 疫苗已被广泛接受。然而,关于患者接种意愿的报道却很少。本研究调查了中国门诊患者接受 COVID-19 疫苗接种的意愿及其影响因素。
2020 年 12 月,在中国江苏省进行了一项横断面调查。向二级医院的 625 名门诊患者发放了自我管理问卷,内容包括人口统计学特征、社会学特征和主观原因。有 522 名(83.5%)参与者给出了完全有效的回复。采用 logistic 回归分析探讨 COVID-19 疫苗接种意愿的危险因素。
71.5%的参与者愿意接种 COVID-19 疫苗。“担心感染 COVID-19”(49.6%)和“疫苗刚推出,需要时间考虑”(38.9%)是愿意和不愿意接种 COVID-19 疫苗的主要原因。logistic 回归分析显示,“疫苗是预防疾病的有效方法”(OR=5.07,95%CI:3.32-7.75)、“愿意支付的非免费疫苗价格(元)(101-500 比≤100)”(OR=1.87,95%CI:1.16-3.02)、“人均月收入(元)(>6000 比≤3000)”(OR=2.13,95%CI:1.03-4.41)和“自我评估健康状况(好比差)”(OR=1.71,95%CI:1.01-2.90)是门诊患者愿意接种 COVID-19 疫苗的主要危险因素。
中国门诊患者接种 COVID-19 疫苗的意愿不高。政府应加大 COVID-19 疫苗知识宣传力度,提高接种意愿,并提供免费疫苗,消除成本影响。